Hematology and Clinical Picture in Pediatric COVID-19 Infection
NCT ID: NCT04487119
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2020-08-12
2020-08-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-field Magnetic Resonance Imaging of Pediatric COVID-19
NCT04990531
Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children
NCT04420468
Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences
NCT04741412
Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan
NCT05582512
Demographic Data and Clinical Presentation of Pediatric Uveitis
NCT06920017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will include in this retrospective study all pediatric patients who were admitted with confirmed COVID-19 infection with age range from birth to 18 years during the period from April 2020 till July 2020. The diagnosis of COVID-19 infection is based on positive SARS-CoV-2 RNA detection in throat swab specimens by PCR.
All data including demography information, contact history, previous history, clinical symptoms, clinical examination on admission, and hematology and laboratory information will be obtained from inpatient medical records.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients transfered to other medical facilities with unknown outcomes,
* patients with age older than 18 years from the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Reda Abdelmaksoud
MD Lecturer pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaimaa R Abdelmaksoud, MD
Role: PRINCIPAL_INVESTIGATOR
Benha University
Rana A Khashaba, MD
Role: STUDY_CHAIR
Benha University
Effat H Assar, MD
Role: STUDY_CHAIR
Benha University
Rasha S Eldesouky, MD
Role: STUDY_CHAIR
Benha University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benha Faculty of Medicine
Banhā, Qalyubia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, Mucheli SS, Kuperan P, Ong KH. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC 6-7-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.